Skip to main content

Table 2 Comparison serum profiles time-course

From: Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling

m/z

p-value

peptide ID

904.4726

0.00054514

BK

1129.4849

0.0013845

FPB

1183.5995

0.0094174

 

1201.5663

0.0045301

 

1263.5958

0.0024011

FPA

1288.6006

0.0013845

 

1347.5297

0.047967

 

1350.6275

0.0013845

FPA

1389.6433

0.0013845

 

1402.671

0.0089624

 

1418.539

0.026155

 

1432.644

0.039554

 

1440.5407

0.011867

 

1445.5828

0.0032159

 

1447.6855

0.005355

 

1450.4893

0.024048

 

1456.5093

0.039554

 

1458.4946

0.020271

 

1460.6257

0.0022586

 

1477.6539

0.010181

 

1479.6646

0.005355

 

1487.6226

0.0017206

 

1491.6634

0.0074232

 

1501.748

0.011

 

1503.5994

0.0087051

 

1507.6643

0.0024697

 

1536.6906

0.0087051

FPA

1552.669

0.003822

Glu-FBP

1561.7288

0.00048292

 

1569.6823

0.0014303

 

1573.7005

0.0022586

 

1616.6366

0.013817

P-FPA

1630.6679

0.0022586

 

1670.5947

0.011876

 

1690.9254

0.03325

C3f

1777.966

0.0087051

C3f

1865.0022

0.011

C3f

2494.1536

0.030814

 

2567.3659

0.00032806

seAlb

2602.3048

0.019183

CF XIIIA

2743.4663

0.005355

 

2747.4349

0.0014303

 

2789.0914

0.037043

 

3156.6207

0.020803

ITIH4

  1. In NSCLC patients, 44 peaks were significantly differential over the three time points: pre-treatment, after two cycles of treatment and end of treatment. Ordered by m/z value. Abbreviations: BK: bradykinin; FBP: fibrinopeptide B; FPA: fibrinopeptide A; Glu-FPB: Glu-1-fibrinopeptide B; P-FPA: phospho-fibrinopeptide A; C3f: complement C3 f; seAlb: serum albumen; CFXIIIA: coagulation factor XIIIA; ITIH4: inter-alpha-trypsin inhibitor heavy chain H4.
Back to article page

Proteome Science

ISSN: 1477-5956